Correlation Between Nascent Biotech and Silo Pharma

Can any of the company-specific risk be diversified away by investing in both Nascent Biotech and Silo Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nascent Biotech and Silo Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Nascent Biotech and Silo Pharma, you can compare the effects of market volatilities on Nascent Biotech and Silo Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nascent Biotech with a short position of Silo Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nascent Biotech and Silo Pharma.

Diversification Opportunities for Nascent Biotech and Silo Pharma

0.58

Correlation Coefficient

Nascent Biotech  Silo Pharma

Very weak diversification

The 3 months correlation between Nascent and Silo is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Nascent Biotech and Silo Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Silo Pharma and Nascent Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nascent Biotech are associated (or correlated) with Silo Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Silo Pharma has no effect on the direction of Nascent Biotech i.e., Nascent Biotech and Silo Pharma go up and down completely randomly.

Pair Corralation between Nascent Biotech and Silo Pharma

Given the investment horizon of 90 days Nascent Biotech is expected to generate 3.78 times less return on investment than Silo Pharma. But when comparing it to its historical volatility, Nascent Biotech is 1.12 times less risky than Silo Pharma. It trades about 0.03 of its potential returns per unit of risk. Silo Pharma is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  90.00  in Silo Pharma on October 9, 2024 and sell it today you would earn a total of  9.00  from holding Silo Pharma or generate 10.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	95.0%
Values	Daily Returns

Nascent Biotech  vs.  Silo Pharma

Nascent Biotech

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Nascent Biotech are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very weak forward indicators, Nascent Biotech displayed solid returns over the last few months and may actually be approaching a breakup point.

Silo Pharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Silo Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy essential indicators, Silo Pharma is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Nascent Biotech and Silo Pharma

The main advantage of trading using opposite Nascent Biotech and Silo Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nascent Biotech position performs unexpectedly, Silo Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Silo Pharma will offset losses from the drop in Silo Pharma's long position.

The idea behind Nascent Biotech and Silo Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.